Expression of the Immunoglobulin Gamma Heavy Chain for Use as a Biochemical Tool by Kukuch, Allison
330
Expression of the Immunoglobulin
Gamma Heavy Chain for Use as a
Biochemical Tool
Allison Kukuch
Indiana University
Chemistry Department
Advisor: Dr. Thomas Tolbert
331
Abstract
From the recent 2005 review of glycosylation of recombinant antibody
therapeutics Jefferis (3) notes that production of therapeutic antibodies with a
consistent human glycoform profile remains a challenge but the development of
customized antibody therapies is an ultimate goal.  Up to this point there have
been attempts to use mammalian derived antibodies, such as from mouse cells,
with unwanted side effects.  This highlights the importance of further research in
the area of antibodies and their possible use as tools for, at the least, therapeutic
use.  One goal of the Tolbert laboratory is to develop a procedure so that yeast
strains can glycosylate proteins with more humanlike glycosylation.  In
preparation, this report focuses on the creation of a yeast strain from which the
IgG Fc protein can be purified in homogeneous form.  To lay the groundwork for
the use of this protein for therapeutic purposes one strain will be produced with a
5’ histidine tag.  Besides aiding in purification this addition will test for stability of
expression, indicating whether small molecule bioactive proteins may be attached
in place of the histidine tag.
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1. Introduction
The glycosylation of Immunoglobulin Gamma (IgG) is important to its form
and function.  Structural analysis done by Krapp et al. (4) found that the alteration
of glycosylation of the CH2 domain generated conformational changes that
reduced binding affinity.  Due to this, purification of a homogeneously
glycosylated IgG Fc heavy chain will be of importance in this project.  So far the
Tolbert lab has been able to express the IgG Fc heavy chain in yeast with the myc
epitope followed by a His six tag on the C-terminus.  Through the purification
process it was found that the glycosylation was heterogeneous and when
deglycosylated the products still showed two distinct bands when run through a
gel.  The hypothesis for this heterogeneity is varied proteolysis of the C-terminal
end of the monomer.  The current objective is to make two subclones of the IgG Fc
heavy chain both without the C-terminal myc epitope or His tag and one with an
N-terminal His tag.  This will allow us to not only see a difference in proteolysis
due to the presence/absence of a His tag but it will also show how positioning of
the His tag on the N-terminus will affect expression. To test over all reduction in
proteolysis a protease deficient strain of yeast will be used.
As described by Brekke and Sandlie (1) in their review of antibodies for
human disease there are three mechanisms through which antibodies can be used:
blocking the action of a specific molecule, targeting specific cells, or functioning
as a signaling molecule.  Through those three functions antibodies can be used to
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treat infectious agents, anti-inflammatory diseases, and cancers to name a few.
The goal here is to understand how our changes to the Fc region will affect its
ability to function properly and have other molecules attached at the hinge region.
From this, expression of the altered Fc region will give us a tool to explore
different possible functions of this modified antibody, which points to a host of
additional projects that can follow.
2. Materials and Methods
2.1 General Procedures
 Growth media and agar plates used for the growth of bacteria were Low
Salt LB and consisted of 2% BactoTM Tryptone, 1% BactoTM Yeast Extract, and
1% NaCl with 2% BactoTM Agar when plates were made.  All BactoTM products
were purchased from Becton, Dickinson, and Company.  For yeast growth and
agar plates YPD was used and consisted of 2% BactoTM Tryptone, 1% BactoTM
Yeast Extract, and 2% Glucose with 2% BactoTM Agar when plates were made.
Also 1M sorbitol (Sigma) was added to media and plates of yeast cells recovering
from electroporation, referred to as YPDS.
PCR was done using 10% 10x Thermo Buffer, 25% 1.25mM dNTP, 20%
10mM of both the 5’ and 3’ primers, and 0.1% TAQ Polymerase.  These
chemicals were purchased from New England Bio Labs. The program named GNT
on the MyCyclerTM from Bio-Rad was used for PCR.  The program started at 94oC
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for three minutes, then 33 cycles of 94oC for 45 seconds, 50oC for 45 seconds, and
72oC for 90 seconds.  After cycling the temperature was held at 72oC for 10
minutes and finally brought down to 4oC at which the samples could be stored
until further use.
Double digests were run with 1ul each of EcoR1 and Not1, 6ul Buffer
EcoR1, 0.6ul BSA, DNA, and water for a total of a 60ul reaction.  Ligations with
2ul DNA Ligase Buffer and 1ul DNA Ligase were run with varying combinations
of plasmid and insert for a total of 20ul. Sequencing reactions consisted of 3ul of
5mM MgCl2, 2ul of 2uM primer, 1ul of ABI Big Dye version 3.1, and DNA
depending upon concentration (20-40ng) to which water was added to reach a total
of 10ul.  Linearization reactions used 2ul AvrII and 16ul of NEB Buffer 2 to every
150ul of DNA.  Unless otherwise noted all chemicals were purchased from New
England Bio Labs.  Measurements of absorbance were taken with a DU Series 500
Spectrophotometer from Beckman.
Electroporation was done using a MicroPulserTM from Bio-Rad.  For
bacteria transformations the program used was Ec1 with a voltage of 1.8 kV for
one pulse.  After electroporation 1ml low salt LB was added and a one-hour
recovery phase in 37oC shake was allowed before plating the cells.  For yeast the
program used was Sc2 with 1.5 kV for one pulse.  After electroporation 1ml of
sorbitol was added and a one-hour recovery at 30oC was followed by the addition
of 2ml of YPD and an additional two-hour growth with shake at 30oC.
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 Agarose gels used for DNA procedures were made from 1% SeaKem LE
Agarose in 60ml of TAE then micro waved for 2.5 minutes after which 2.5ul of
ethidium bromide was added.  Model B1 Class II gel boxes from Owl Separation
Systems Inc. powered by the Power Pac Basic from Bio-Rad Laboratories were
used to run agarose gels.  A UV Transilluminator Model M-15 by UVP was used
to visualize the agarose gels.  Acrylamide gels for protein procedures were made
with a 15% Resolving Gel base topped off with a 5% Stacking Gel and run in Mini
Protean 3 Cell boxes powered by the Power Pac Basic.  Resolving Gels consisted
of 15% dilution of 30% Acrylamide/Bis Solution, 1.5 M Tris at pH 8.8, and 10%
SDS.  At the time of making the gels 10% ammonium persulfate and 5% TEMED
were added.  For the Stacking Gel a 5% dilution of 30% Acrylamide/Bis Solution,
1.0 M Tris at pH 6.8, and 10% SDS were combined to which 10% ammonium
persulfate and 5% TEMED were added when the gel was made.  All chemicals for
gel procedures were obtained from Bio-Rad Labs.  After acrylamide gels were run
the following stain and de-stain procedure was used to view the protein bands.
Enough quick stain (25% isopropanol, 10% acetic acid, and 0.05% comassie blue)
was used to cover the gel, which was micro waved for one minute on high and
then removed.  Next enough quick de-stain (10% acetic acid and 10% isopropanol)
was used to cover the gel, which was again micro waved for one minute and
removed.  Finally enough slow de-stain (10% acetic acid and 30% methanol) to
cover the gel was added and left at room temperature on a rotator plate until
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sufficiently de-stained.  Gels were dried using DryEase Mini Cellophane and Gel-
Dry Drying solution from Invitrogen in a drying rack.
Protease deficient yeast cells (SMD1168H) were made competent for
electroporation by the following procedure adapted from Shixuan Wu and
Geoffrey Lechworth (5).  A 2ml culture from frozen stock was grown in YPD
overnight from which 50ul and 10ul samples were used to inoculate two 50ml
cultures of YPD in baffled flasks in a 30oC shake.  These cultures were allowed to
grow until the O.D. 600 was 1.5.  The cells were then spun at 2.4krpm for 10
minutes.  The pellet was resuspended in 8ml of resuspension solution containing
100mM LiAc, 0.6M sorbitol, 10% 1M DTT, and 0.7% 1.5M TrisHCl.  Incubation
at room temperature for 30 min was done before the cells were pelleted again.
Three washes with 1.5ml ice-cold sorbitol were done for a final volume of 1.5ml
of sorbitol.  The cells were stored on ice before use within the same day.
The Bust n’ Grab technique from Harju et al. (2) was adapted here to
extract DNA from yeast cells.  Cells picked from plates were suspended in 100ul
lysis buffer (2% Triton X-100, 1% SDS, and 100mM Tris-HCl pH 8.0).  The cells
were frozen at -80oC for 10 minutes and transferred to a 95oC water bath for one
minute.  The freeze-thaw cycle was repeated after which the cells were vortexed
for 30 seconds.  100ul of chloroform was added and the cells were vortexed for
two minutes.  Centrifugation was done for three minutes and the upper aqueous
phase was transferred to a new tube containing 400ul of cold ethanol with gentle
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mixing.  The solution was then incubated at -20oC for at least five minutes.  After
five minutes of centrifugation the ethanol was removed and the pellet was allowed
to dry.  The DNA was resuspended using 50ul of EB solution from the QIA kits.
Small-scale expression trials were performed in 12 well plates kept at 30oC
with shaking.  Each well contained 2ml of YPD and zeocin at 100ug/ml (except
for the SMD control well).  Glucose (1%) was added each day and to prevent
evaporation sterile water was added as needed to keep all wells at the same level.
2.2 Cloning
 The IgG Fc DNA from MGC12857 was grown over night in low salt LB
with 35ug/ml chloramphenicol to ensure selection of the vector.  The plasmid was
then purified from the bacterial cells using QIA prep Spin Mini Prep Kit.  Two
PCR reactions with a 50ul volume each were run with two different primers on
program GNT.  Primers for the cell line now called ‘His’ are as followed
 5’-EcoR1-His6-IgG
  gcgccgGAATTCcatcatcatcatcatcatacatgcccaccgtgcccagca
 3’-IgG-STOP-NOT1
  gggcccgcgGCGGCCGCttatttacccggagacagggagg
Primers for the cell line ‘No’ are as follows
 5’-IgGFc-EcoR1-PP
  gcgccgGAATTCacatgcccaccgtgcccagca
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 3’-IgG-STOP-NOT1
  gggcccgcgGCGGCCGCttatttacccggagacagggagg
PCR products were run on an argarose gel and purified with the QIA Quick Gel
Extraction Kit.
The plasmid pGAPZ?A from Top10F’ was grown over night in low salt LB
with 25ug/ml zeocin and then collected via the QIA Mini Prep kit.  The plasmid
was purified through argarose gel and then the QIA Gel Extraction kit.  Both PCR
products and the pGAP plasmid, 45ul, were digested with EcoR1 and Not1 in a
double digest for 2 hours at 37oC.  For one additional hour 1ul CIP was added to
the plasmid digest only to prevent recircularization.  QIA Quick PCR Purification
Kit was used to purify the digests.  Ligations were done at room temperature for
one hour with 7ul of both plasmid and insert along with a control that contained
only plasmid.
2.3 Electroporation
Electroporation using Top 10F’ bacterial cells was done for each of the
three ligations.  For this procedure 1ul of the ligation was added to 80ul of cells
then the cells were shocked, after which 800ul low salt LB was added and the cells
were allowed to recover for one hour at 37oC.  100ul and 200ul of cells each for
His and No were plated with zeocin.  100ul of the control was plated with zeocin
and all plates were grown overnight at 37oC.
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 Cells that grew were picked for sequencing reactions to check for correct
insertion of the DNA and to make sure that there were no mutations.  First
overnight growths of each colony were grown in low salt LB and zeocin.  Next
plasmid mini preps were done and a gel was run to check that the plasmids were of
the correct size.  These plasmids were then PCR checked to ensure insertion of the
IgG DNA.  Cells that passed both tests were sent to the Indiana Molecular Biology
Institute for sequencing from the 5’a mating factor and 3’ AOX.  Frozen stocks
were made from colonies that were correctly sequenced.
2.4 Yeast Transformation
 Over night one His and one No colony were grown in low salt LB and the
purified plasmids were linearized with Avr II.  QIA PCR Clean Kit was used to
purify the linear DNA and the absorbance was taken to determine the
concentration of DNA.  Yeast cells SMD1168H were made competent as
described above.  For transformation 1-3ug of DNA was added to 80ul of cells.
After electroporating the cells 1ml of sorbitol was added for a one-hour recovery
at 30oC.  Then 2ml YPD was added and the cells were allowed to shake at 30oC
for two hours.  The cells were plated on YPDS plates with 100ug/ml zeocin.  For
both His and No the following plates were made: two 50ml, two 100ml, and one
250ml.  A control plate with zeocin of SMD cells that did not undergo
transformation was plated with 100ul of cells.  Also plates without zeocin were
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made with 100ul for both His and No.  All of these plates were allowed to grow
for four days at 30oC.  Colonies that grew under the 100ug/ml selection were
plated on 500ug/ml zeocin and the colonies that were able to grow were used for
small-scale expression.
2.5 Yeast Expression
 Small-scale yeast expression was done with the addition of 1% glucose
every 24 hours.  Samples of 50ul were taken out at 48, 72, 96, and 120 hours.
These samples were spun at 6krpm for 5 minutes from which 40ul of the
supernatant was taken.  10ul of 4x protein dye was added and vortexed.  After 5
minutes at 95oC the samples were run on 15% agarose gel along with the size
marker Mark 12 MW Standard.  Gels were then stained, de-stained, and dried so
that the protein bands could be seen.
3. Results and Discussion
 PCR amplification of the IgG insert DNA was successful but digestion and
ligation posed a few problems.  After ensuring that both enzymes were able to do a
single digestion the double digestion was done with differing amounts of plasmid
versus insert.  Finally it was found that using 8ul of each produces many colonies.
This is due to the fact that the plasmid is many-fold larger than the insert so an
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equal volume will ensure that there will be more copies of insert for every
plasmid.
l Bste II N6     N5     N3    N2    N1    H6     H5     H4     H3    H2     H1
pGAP
Figure 1 Agarose gel of plasmid size check for inclusion of insert into the plasmid
Plates that were grown from the ligations showed there were 50% background
colonies.  Due to this, size exclusion via agarose gel was done as shown in figure
1.  Only the colonies that showed a larger size than the original pGAP plasmid
were tested further (N3, N1, H6, H5, H4, H3, H2, H1).
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            700bp
                 N3       N1     H6      H5      H4       H3      H2      H1 l Bste II
Figure 2 Agarose gel of PCR products to check for insert
To ensure that the chosen colonies contained the insert PCR was done on each
colony.  As seen in figure 2 all colonies checked by size were confirmed to have
the IgG insert.  From these colonies two for each construct were chosen for
sequencing (H1, H2, N1, and N3).  The first sequencing produced a 900bp read
through from both directions for H1 while the others were not sufficiently
sequenced.  The samples were sent back with an increase in DNA concentration
slightly over the amount suggested in the online protocol from the Indiana
University Molecular Biology DNA Sequencing Facility.  The second set of
sequences produced a complete read through of 800bp from both directions for
N1.  Frozen stocks of these two colonies were made for future use.
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                                                             His     His      No      No
      plasmid linear  plasmid linear
Figure 3 Linearization of both the His and No plasmids
After a few trials it was found that linearization using Avr II was optimal
after an overnight digestion as seen in figure 3.  Electroporation of the SMD cells
proved to be challenging.  The first attempt had significant contamination.  Then
after two attempts, which produced few colonies, a transformation that produced
100 to 300 colonies per plate was achieved.  Again there was a 50% background
but 28 colonies (with three controls) were selected and checked for insertion of the
IgG DNA.  While the insert was confirmed and a small-scale expression was done,
contamination was found so the procedure was repeated.
 In the subsequent transformations, small numbers of colonies were again
produced; therefore before moving to small-scale expression a selection on higher
zeocin concentrations were performed. This was done to identify multiple
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integrants.  A cell line with more than one copy of the IgG gene should be able to
produce higher yields of the protein and is therefore preferred over single integrant
strains.  Due to the low number of colonies produced in the transformations thus
far additional transformations will be performed.  With the high colony number
that will be expected in new transformations the cells can be selected for multiple
integrants in liquid cultures instead of on plates.  Through this process cells can be
selected in up to 2000ug/ml zeocin.
Figure 4 Control plates for transformation
Figure 5 Plates with transformed IgG with histidine tagged colonies
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Figure 6 Plates with transformed IgG colonies without the histidine tag
While the colony count continues to be low, figure 4 shows that the contamination
problem has been corrected with the non-zeocin plate showing a lawn of colonies
while the zeocin containing plate did not allow cells that were not transformed to
grow.
     HA     HB    HC     HD     HE      HF      HI       NJ     NK   Blank lBste II
Figure 7 PCR check of insertion of IgG DNA
A PCR check of the insertion of IgG was done on the selected colonies
showing that HA did not have the DNA insert (figure 7).  Due to the fact that the
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Bust ‘n Grab protocol used can sometimes not yield results HA was not excluded
from further analysis.
 HA   HB    HC   HE    HF    HI  NJ   NK  SMD Marker  HA   HB    HC   HE    HF    HI  NJ   NK  SMD
Marker
Figure 8 Days two and three of small-scale expression
ß 40kDa
HA  HB   HC   HD HE   HF  HI   NJ  NKSMD Marker       HA HB  HC  HD  HE  HF  HI NJ  NK SMD
Marker
Figure 9 Days four and five of small-scale expression
Small-scale expression was done showing that there was a product made in
the transformed cells (at 40kDa) that was not made in the control of SMD cells
(poor picture quality does not show all bands present in the gel).  This indicates
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that IgG protein is being made.  Knowing that the DNA is inserted and the protein
can be made, transformations to achieve high integrant cell lines are currently
being done.
Future plans include but are not limited to large-scale expression of the best
protein expressers from the small-scale expression, purification of IgG,
quantification of the amount being expressed, and characterization of the protein
to look for proteolysis.  Testing of the IgG with the histidine tag will be essential
to ensure that the protein can function with additional amino acids attached.  If this
His protein can function correctly the attachment of other bioactive molecules in
place of the histidine tag will be done.  Ultimately it is this attachment of other
bioactive molecules that will confirm the ability for IgG to be used as a
biochemical tool.
 Alpha-mannosidase II was also being expressed at the same time as the
above expression of IgG.  The procedures that were performed included
linearization, transformation, electroporation, and small-scale expression in both
the SMD1168H and GS115 yeast cells.  Also a large-scale expression and
purification from the GS115 cell line was done.
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